Table 1.
Characteristics | BE* (N = 20) | Non-BE (N = 62) | P |
---|---|---|---|
Age, years | 14.1 (1.2) | 14.1 (1.2) | 0.97 |
Weight, kg | 103 (16) | 103 (15) | 0.99 |
BMI, kg/m2 | 38.4 (3.8) | 37.5 (3.8) | 0.37 |
BMI z-score | 2.5 (0.2) | 2.4 (0.2) | 0.12 |
Waist circumference, cm | 110 (12) | 109 (11) | 0.74 |
Gender, N (%) | |||
Male | 10 (37%) | 17 (63%) | 0.06 |
Female | 10 (18%) | 45 (82%) | |
Race, N (%) | |||
Non-Caucasian | 7 (19%) | 30 (81%) | 0.30 |
Caucasian | 13 (29%) | 32 (71%) | |
Treatment Group, N (%) | |||
Placebo | 13 (33%) | 26 (67%) | 0.07 |
Drug | 7 (16%) | 36 (84%) |
Values shown are mean (SD) or number (N) of participants.
BE represents a collapsed variable including participants meeting full criteria for BED, as well as those who met sub-threshold criteria. These two conditions were collapsed into a single BE sample, due to a lack of difference between groups.